Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
British Journal of Haematology
|
August 24, 2023
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation
Shlomo Elias, Samantha Brown, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 23, 2017
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
Satyajit Kosuri, Diego Adrianzen Herrera, Michael Scordo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 6, 2017
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation
Michael Scordo, Gunjan L Shah, Satyajit Kosuri, et al.
Transplantation and Cellular Therapy
|
July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR
Antonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.
Blood Advances
|
March 6, 2025
Transplant Outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR Analysis
Karthik Nath, Mei-Jie Zhang, Matthew Bye, et al.
Blood Advances
|
June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
Roni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
Blood Advances
|
November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
The Lancet. Haematology
|
December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
Michael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
Transplantation and Cellular Therapy
|
April 13, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations
Moataz Ellithi, Sandeep Raj, Maria Bromberg, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
British Journal of Haematology
|
August 24, 2023
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation
Shlomo Elias, Samantha Brown, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 23, 2017
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
Satyajit Kosuri, Diego Adrianzen Herrera, Michael Scordo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 6, 2017
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation
Michael Scordo, Gunjan L Shah, Satyajit Kosuri, et al.
Transplantation and Cellular Therapy
|
July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR
Antonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.
Blood Advances
|
March 6, 2025
Transplant Outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR Analysis
Karthik Nath, Mei-Jie Zhang, Matthew Bye, et al.
Blood Advances
|
June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
Roni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
Blood Advances
|
November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
The Lancet. Haematology
|
December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
Michael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
Transplantation and Cellular Therapy
|
April 13, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations
Moataz Ellithi, Sandeep Raj, Maria Bromberg, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Page
of 8